or Try an Advanced Search...

    Non Muscle Invasive Bladder Cancer Stocks List

    Symbol Grade Name % Change
    URGN F UroGen Pharma Ltd. -3.72
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Antineoplastic Drugs Biopharmaceutical Bladder Cancer Botulinum Toxin Cancer Carcinoma Chemotherapy Immunotherapy Interstitial Cystitis Medicine Oab Overactive Bladder Platform Technologies Surgery Tlr7 Two Platform Technologies Urinary Bladder

    Related ETFs - A few ETFs which own one or more of the above listed Non Muscle Invasive Bladder Cancer stocks.

    Symbol Grade Name Weight
    IZRL C ARK Israel Innovative Technology ETF 2.18
    ITEQ D BlueStar TA-BIGITech Israel Technology ETF 0.59
    BTEC D Principal Healthcare Innovators Index ETF 0.14
    IWC C iShares Microcap ETF 0.11
    VFMO C Vanguard U.S. Momentum Factor ETF 0.06
    View all Non Muscle Invasive Bladder Cancer ETFs...
    Compare ETFs
    Compare ITEQ to BTEC Compare ITEQ to VFMO Compare IZRL to VFMO

        Non Muscle Invasive Bladder Cancer Stocks Recent News

        Date Stock Title
        Apr 17 URGN UroGen Announces New Data Presentations at the American Urological Association 2024 Annual Meeting Highlighting Clinical Benefits of Our Portfolio for Urothelial Cancers
        Apr 15 URGN UroGen Announces FDA Acceptance of Investigational New Drug Application for UGN-103, a Next Generation Mitomycin-Based Formulation for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
        Apr 14 URGN UroGen Pharma Ltd.'s (NASDAQ:URGN) high institutional ownership speaks for itself as stock continues to impress, up 11% over last week
        Related Industries: Biotechnology
        Related Stock Lists: Antineoplastic Drugs Biopharmaceutical Bladder Cancer Botulinum Toxin Cancer Carcinoma Chemotherapy Immunotherapy Interstitial Cystitis Medicine Oab Overactive Bladder Platform Technologies Surgery Tlr7 Two Platform Technologies Urinary Bladder
        Non Muscle Invasive Bladder Cancer

        Non-muscle invasive bladder cancer (NMIBC) is a type of bladder cancer that has not spread beyond the inner lining of the bladder. It is also known as superficial bladder cancer. NMIBC is usually treated with surgery, but may also be treated with chemotherapy, immunotherapy, or radiation therapy.

        Browse All Tags